Direkt zum Inhalt
Merck

Failure of the biguanide moroxydine chloride to stimulate plasma fibrinolytic activity.

Acta medica Scandinavica (1984-01-01)
M Boberg, A Killander
ZUSAMMENFASSUNG

Eleven patients with recurrent venous thrombosis or thrombophlebitis and a decreased fibrinolytic activity after venous occlusion were given a phenformin-like substance, moroxydine chloride, for 6 months. No sustained increase in the fibrinolytic activity was observed after moroxydine treatment.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Moroxydin -hydrochlorid, 99%